Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nuvectis Pharma Receives Orphan Drug Designation Granted By FDA For NXP800 In Treatment Of ARID1a-deficient Ovarian, Fallopian Tube And Primary Peritoneal Cancers

Author: Benzinga Newsdesk | August 29, 2024 08:02am

Posted In: NVCT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist